Arcadia Capital Group
  • Home
  • About
  • Arcadia AI
  • Nicholas Mitsakos
  • The Team
  • Writing and Podcasts
  • YouTube
  • Books
  • Contact
Select Page
Biotechnology – Volatile, Risky, and Extraordinary

Biotechnology – Volatile, Risky, and Extraordinary

by Nicholas Mitsakos | Biotechnology, Economy, Investments, Writing and Podcasts

Biotechnology has been beaten up a lot lately and has had a very volatile and unimpressive recent history. However, biotechnology is still one of the single greatest investment opportunities available, and new and exciting factors are developing and enhancing the attractiveness of the sector

Next Entries »

Recent Writing

  • The Real World and AI
  • The Computable Molecule
  • The AI Molecule
  • The Next Human Crisis
  • The Application Layer
  • The Price-to-Dream Ratio
  • The New Software Stack
  • Capturing AI
  • Reimagining Software
  • Space – The New Version
  • Blame Prometheus
  • The Wheel, the Cart, and AI Systems

Categories

  • Home
  • About Arcadia Capital Group
  • Contact
  • Nicholas Mitsakos
  • Writing and Podcasts
  • YouTube
  • Books
  • Economy
  • Investments
  • Biotechnology